

[ Fri, Dec 22nd 2023
] - WOPRAI

[ Wed, Nov 08th 2023
] - WOPRAI

[ Tue, Jul 18th 2023
] - WOPRAI

[ Tue, Mar 07th 2023
] - WOPRAI

[ Fri, Feb 17th 2023
] - WOPRAI

[ Thu, Nov 10th 2022
] - WOPRAI

[ Thu, Oct 13th 2022
] - WOPRAI

[ Tue, Sep 20th 2022
] - WOPRAI

[ Mon, Aug 29th 2022
] - WOPRAI


[ Wed, Aug 03rd 2022
] - WOPRAI

[ Tue, Aug 02nd 2022
] - WOPRAI



[ Thu, May 05th 2022
] - WOPRAI

[ Tue, Nov 16th 2021
] - WOPRAI

[ Wed, Nov 10th 2021
] - WOPRAI

[ Fri, Oct 08th 2021
] - WOPRAI

[ Fri, Sep 24th 2021
] - WOPRAI

[ Thu, Sep 23rd 2021
] - WOPRAI

[ Tue, Jul 13th 2021
] - WOPRAI

[ Tue, Jun 29th 2021
] - WOPRAI

[ Wed, Feb 24th 2021
] - WOPRAI

[ Tue, Nov 10th 2020
] - WOPRAI

[ Mon, Oct 26th 2020
] - WOPRAI

[ Fri, Oct 16th 2020
] - WOPRAI
[ Fri, Oct 16th 2020
] - WOPRAI

[ Tue, Sep 22nd 2020
] - WOPRAI

[ Tue, Jul 28th 2020
] - WOPRAI


[ Mon, Mar 30th 2020
] - WOPRAI






[ Fri, Mar 15th 2019
] - WOPRAI
[ Fri, Mar 15th 2019
] - WOPRAI

[ Mon, Sep 10th 2018
] - WOPRAI

[ Wed, Dec 20th 2017
] - WOPRAI




[ Tue, Mar 01st 2016
] - WOPRAI
Dane Leone Maintained (BPMC) at Strong Buy with Increased Target to $100 on, Dec 22nd, 2023
Dane Leone of Raymond James, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $85 to $100 on, Dec 22nd, 2023.
Dane has made no other calls on BPMC in the last 4 months.
There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 2 agree with Dane's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023
- Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $58 on, Friday, October 27th, 2023
These are the ratings of the 4 analyists that currently disagree with Dane
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
- Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023
- Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023